Vital BLOG
Translation and interpretation are usually considered the same type of language service. However, these two language services have different approaches and serve distinct purposes in the...
Translating medical and pharmaceutical texts requires linguistic expertise, translation studies, but, most importantly, background knowledge of different scientific disciplines such as...
Para acceder a este campo laboral tan técnico y especializado, y ofrecer traducciones que contribuyan a los procesos de los clientes, el traductor debe...
Due to the highly regulated nature of the pharma industry, lots of documents are generated (and need to be translated). Documents containing information about...
VitalUNI is a training platform developed by Vital Translations. Our senior specialised medical translators have developed courses to address the need of an integral training in medical and pharmaceutical translation.
Los traductores que deseen especializarse en el campo de la traducción médica y farmacéutica deben formarse en química, bioquímica, anatomía, fisiología, farmacología, farm...
Highlighted Articles
By slowing progression of the disease when taken in the early stages of Alzheimer's, donanemab can allow people to have more time to participate in daily life and live independently.
- Clinical Research, Neurology, Patients, Pharma & Biotech, Therapeutic Areas, Translation Services
Evidence from RCTs and real-world data consistently shows that discontinuation leads to reversal of cardiometabolic improvements and restoration of prior risk factors.
- Clinical Research, Endocrinology, Therapeutic Areas, Translation Services
Pfizer and Innovent Biologics have entered into a collaboration agreement for the research and development of a portfolio of antibody-drug conjugates (ADCs).
- Clinical Research, Community, Immunology, Oncology, Targeted Therapies, Translation Services
EDIT-101 is a gene-editing therapy mediated by clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated protein 9 (Cas9) that is designed to permanently remove the CEP290 IVS26 variant.
- Clinical Research, Community, Ophthalmology, Therapeutic Areas, Translation Services
The findings represent the first clinical data for this KIR-CAR, which uses natural killer (NK) cell-like receptors to overcome T cell exhaustion and limit side effects.
- Clinical Research, Oncology, Patients, Targeted Therapies, Therapeutic Areas, Translation Services
Artificial intelligence (AI) moves R&D from a sequential trial-and-error model to a predictive, data-driven architecture.
- Artificial Intelligence, Clinical Research, Laboratories, Pharmaceutical Industry, Translation Services